State Board Of Administration Of Florida Retirement System Glycomimetics Inc Transaction History

State Board Of Administration Of Florida Retirement System

$50.1 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$2.16 - $3.18 $21,921 - $32,273	-10,149 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$1.83 - $5.41 $366 - $1,082	-200 Reduced 1.93%	10,149 $23,000
Q2 2019 Aug 05, 2019	BUY	$10.6 - $13.12 $109,699 - $135,778	10,349 New	10,349 $123,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

25.6M

Call Options Held

1.94M

Put Options Held

153K

Bvf Inc San Francisco, CA

9.54M
Shares

$1.62 Million
0.08% of portfolio
Artal Group S.A. Luxembourg, N4

8.59M
Shares

$1.46 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

2.7M
Shares

$458,474
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

827K
Shares

$140,564
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

804K
Shares

$136,738
0.0% of portfolio

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $8.91M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account